alzheimer (MedPage Today) -- Phase II trial data showed that sumifilam, an investigational drug that binds to filamin A, significantly improved a panel of Alzheimer's biomarkers and showed trends toward cognitive improvement in patients with mild-to-moderate...


Read full article on MedPage Today Neurology



MSChristian.org RSS Statement

Most of the information found on this website comes from RSS Feeds. It is an automated task that provides the information to you. We try to limit items that are duplicates, but with many feeds this can be difficult. Since the owner of this website also has MS and is legally blind this service was necessary to keep the website running with as much automation as possible. Volunteers help from time to time but many have disabilities themselves. We thank you for visiting us and hope that MSC can be of service to you and your loved ones.